Modulation of estrogen receptor-β isoforms by phytoestrogens in breast cancer cells

International Journal of Oncology

Volumn 28, Issue 5, 2006, Pages 1185-1191

  Cappelletti, Vera ^a   Miodini, Patrizia ^a   Di Fronzo, Giovanni ^b   Daidone, Maria Grazia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

Breast cancer; Cell growth; Estrogen receptor splicing variants; Genistein; Quercetin

Indexed keywords

ESTROGEN RECEPTOR BETA; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN; PRIMER DNA; QUERCETIN;

ARTICLE; BREAST TUMOR; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; PHYTOESTROGENS; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33646834937     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.5.1185     Document Type: Article

References (25)

1. Upmalis DH, Lobo R, Bradley L, Warren M, Cone F and Lamia CA: Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo controlled study. Menopause 7: 236-242, 2000.
2. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A and Bundred NJ: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Endocrinol Metab 84: 4017-4024, 1999.
3. Miodini P, Fioravanti L, Di Fronzo G and Cappelletti V: The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer 80: 1150-1155, 1999.
4. Kuehnau J: The flavonoids, a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24: 117-191, 1976.
5. Scambia G, Ranelletti FO, Benedetti-Panici P, Piantelli M, De Vincenzo R, Ferrandina G, Bonanno G, Capelli A and Mancuso S: Quercetin induces type-II estrogen binding sites in estrogen receptor negative (MDAMB-231) and estrogen receptor positive (MCF-7) breast cancer cell lines. Int J Cancer 54: 462-466, 1993.
6. Singhal RL, Yeah YA, Prajda N, Olah E, Sledge GS and Weber G: Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 208: 425-431, 1995.
7. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997. (Pubitemid 27089735)
8. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljungren J, Gustafsson JA and Carlquist M: Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18: 4608-4618, 1999.
9. Adlercreutz H and Mazur W: Phyto-oestrogens and Western diseases. Ann Med 29: 95-120, 1997.
10. Pettersson K, Delaunay F and Gustafsson JA: Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 19: 4970-4978, 2000.
11. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MRJ and Hanby AM: Oestrogen receptor β: what it means for patients with breast cancer (Review). Lancet Oncol 5: 174-181, 2004.
12. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM and Willson TM: Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 247: 75-78, 1998.
13. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y and Muramatsu M: Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 26: 3505-3512, 1998.
14. Vladusic EA, Hornby AE, Guerra-Vladusic FK and Lupu R: Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res 58: 210-214, 1998.
15. Iwao K, Miyoshi Y, Egawa C, Ikeda N and Noguchi S: Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancer. Int J Cancer 88: 733-736, 2000.
16. Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S and Zeillinger R: Expression of estrogen receptor beta isoforms in breast cancer tissues and cell lines. Breast Cancer Res Treat 71: 249-255, 2002.
17. Peng B, Lu B, Leygue E and Murphy LC: Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30: 13-29, 2003.
18. Resch A, Xing Y, Modrek B, Gorlick M, Riley R and Lee C: Assessing the impact of alternative splicing on domain interactions in the human proteome. J Proteome Res 3: 76-83, 2004.
19. Cappelletti V, Saturno G, Miodini P, Körner W and Daidone MG: Selective modulation of ER-β by estradiol and xenoestrogens in human breast cancer cell lines. Cell Mol Life Sci 60: 567-576, 2003.
20. Cicatiello L, Ambrosino C, Coletta B, Scalona M, Sica V, Bresciani F and Weisz A: Transcriptional activation of jun and actin genes by estrogen during mitogenic stimulation of rat uterine cells. J Steroid Biochem Mol Biol 41: 523-528, 1992.
21. Leygue E, Dotzlaw H, Watson PH and Murphy LC: Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res 59: 1175-1179, 1999.
22. 2M phase of the cell cycle. J Cell Biochem 79: 594-600, 2000.
23. Limer JL and Speirs V: Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 6: 119-127, 2004.
24. Fioravanti L, Cappelletti V, Miodini P, Ronchi E, Brivio M and Di Fronzo G: Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett 130: 143-152, 1998.
25. Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y and Hayashi S: Estrogen receptor (ER) beta1 and betacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7. Oncogene 22: 5011-5020, 2003.